Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Lijuan Zhao, An Liu & Guoshuang Xu. (2021) Safety and effectiveness of lanthanum carbonate for hyperphosphatemia in chronic kidney disease (CKD) patients: a meta-analysis. Renal Failure 43:1, pages 1378-1393.
Read now
Read now
Akira Matsuo, Akio Iida, Minako Tanimoto, Mutsuyoshi Matsushita & Ken-ichi Miyamoto. (2014) The utility of the phosphate binder, ferric citrate hydrate (JTT-751), about phosphorus absorption-reducing effect in normal rats. Renal Failure 36:8, pages 1291-1297.
Read now
Read now
MªJesús Lloret, César Ruiz-García, Iara DaSilva, Mónica Furlano, Yaima Barreiro, José Ballarín & Jordi Bover. (2013) Lanthanum carbonate for the control of hyperphosphatemia in chronic renal failure patients: a new oral powder formulation – safety, efficacy, and patient adherence. Patient Preference and Adherence 7, pages 1147-1156.
Read now
Read now
Makrouhi Sonikian, Evangelos Papachristou & Dimitrios S Goumenos. (2013) Optimal use of phosphate binders in chronic kidney disease. Expert Opinion on Pharmacotherapy 14:18, pages 2521-2532.
Read now
Read now
Articles from other publishers (9)
Xiaojun Wang, Yanping Xu, Xiaohong Yu, Asim Dey, Hong Y. Zhang, Charity M. Zink, Derek Wodka, Gina Porter, William F. Matter, Leah Porras, Charles A. Reidy, Jeffrey A. Peterson, Brian E. Mattioni, Joseph V. Haas, Mark C. Kowala & John R. Wetterau. (2022) Effects of pharmacological inhibition of the sodium‐dependent phosphate cotransporter 2b (NPT2b) on intestinal phosphate absorption in mouse and rat models. Pharmacology Research & Perspectives 10:2.
Crossref
Crossref
Andrew J. King, Jill Kohler, Cyra Fung, Zhengfeng Jiang, Allison Quach, Padmapriya Kumaraswamy, Glenn M. Chertow & David P. Rosenbaum. (2021) Combination treatment with tenapanor and sevelamer synergistically reduces urinary phosphorus excretion in rats. American Journal of Physiology-Renal Physiology 320:1, pages F133-F144.
Crossref
Crossref
Anna Janus, Michał Holecki, Anna Hawrot- Kawecka & Grzegorz Kawecki. (2020) Knowledge of haemodialysis patients concerning methods of preventing hyperphosphataemia. Annales Academiae Medicae Silesiensis 74, pages 46-59.
Crossref
Crossref
Xiaojiao Sun, Dechao Zhao, Fangping Lu, Shuo Peng, Miao Yu, Ning Liu, Yu Sun, Haining Du, Bingzhu Wang, Jian Chen, Shiyun Dong, Fanghao Lu & Weihua Zhang. (2019)
Hydrogen sulfide regulates muscle RING finger‐1 protein S‐sulfhydration at Cys
44
to prevent cardiac structural damage in diabetic cardiomyopathy
. British Journal of Pharmacology 177:4, pages 836-856.
Crossref
Crossref
Wander Barros do Carmo, Bárbara Bruna Abreu Castro, Clóvis Antônio Rodrigues, Melani Ribeiro Custódio & Helady Sanders-Pinheiro. (2018) Chitosan-Fe (III) Complex as a Phosphate Chelator in Uraemic Rats: A Novel Treatment Option. Basic & Clinical Pharmacology & Toxicology 122:1, pages 120-125.
Crossref
Crossref
Tamara Isakova, Joachim H. Ix, Stuart M. Sprague, Kalani L. Raphael, Linda Fried, Jennifer J. Gassman, Dominic Raj, Alfred K. Cheung, John W. Kusek, Michael F. Flessner, Myles Wolf & Geoffrey A. Block. (2015) Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD. Journal of the American Society of Nephrology 26:10, pages 2328-2339.
Crossref
Crossref
Eric D. Labonté, Christopher W. Carreras, Michael R. Leadbetter, Kenji Kozuka, Jill Kohler, Samantha Koo-McCoy, Limin He, Edward Dy, Deborah Black, Ziyang Zhong, Ingrid Langsetmo, Andrew G. Spencer, Noah Bell, Desiree Deshpande, Marc Navre, Jason G. Lewis, Jeffrey W. Jacobs & Dominique Charmot. (2015) Gastrointestinal Inhibition of Sodium-Hydrogen Exchanger 3 Reduces Phosphorus Absorption and Protects against Vascular Calcification in CKD. Journal of the American Society of Nephrology 26:5, pages 1138-1149.
Crossref
Crossref
Tsuyoshi Takashima, Toru Sanai, Motoaki Miyazono, Makoto Fukuda, Tomoya Kishi, Yasunori Nonaka, Mai Yoshizaki, Sae Sato & Yuji Ikeda. (2014) A Comparison of the Long-Term Effects of Lanthanum Carbonate and Calcium Carbonate on the Course of Chronic Renal Failure in Rats with Adriamycin-Induced Nephropathy. PLoS ONE 9:5, pages e97859.
Crossref
Crossref
David Pierce, Stuart Hossack, Antoine Robinson, Pinggao Zhang & Patrick Martin. (2012) Assessment of Pharmacodynamic Equivalence and Tolerability of Lanthanum Carbonate Oral Powder and Tablet Formulations: A Single-Center, Randomized, Open-Label, 2-Period Crossover Study in Healthy Subjects. Clinical Therapeutics 34:6, pages 1290-1300.e2.
Crossref
Crossref